CCI
NXTM

Columbus Circle Investors’s NxStage Medical Inc. NXTM Stock Holding History

Columbus Circle Investors’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-370,022
Closed -$9.25M – 328
2016
Q3 		$9.25M Buy
370,022
+159,355
+76% +$3.72M 0.1% 170
2016
Q2 		$4.57M Buy
+210,667
New +$3.76M 0.05% 201

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Columbus Circle Investors's NXTM Position: Q4 2016 in Review

Columbus Circle Investors sold out of NxStage Medical Inc. (NXTM) in Q4 2016, closing a stake of 370,022 shares — an estimated $9.25M sold.

Columbus Circle Investors first reported a position in NXTM in Q2 2016 and held it in 2 quarters. The position peaked at $9.25M in Q3 2016. 170 funds tracked by Wall St. Rank hold NXTM as of Q4 2016.

  • Columbus Circle Investors reported no remaining NxStage Medical Inc. position as of Q4 2016 after selling out during the quarter.
  • Columbus Circle Investors sold 370,022 NxStage Medical Inc. shares in Q4 2016, an estimated $9.25M.
  • Columbus Circle Investors first reported a position in NxStage Medical Inc. in Q2 2016 and held it in 2 quarters.
  • Columbus Circle Investors's NxStage Medical Inc. position peaked at $9.25M in Q3 2016.
  • 170 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2016.

Based on Columbus Circle Investors's 13F filing for Q4 2016, filed 2 Feb 2017.